[{"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0376-2024", "product_description": "TRP Blur Relief, Sterile Eye Drops, Homeopathic 0.5 FL OZ (15mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-002-11.", "product_quantity": "7,248 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: B905, Exp: 07-13-2025"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204629"], "brand_name": ["JARDIANCE"], "generic_name": ["EMPAGLIFLOZIN"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0152", "0597-0153"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EMPAGLIFLOZIN"], "rxcui": ["1545658", "1545664", "1545666", "1545668"], "spl_id": ["2669be16-3d07-4426-a711-aac76ce3d3c9"], "spl_set_id": ["faf3dd6a-9cd0-39c2-0d2e-232cb3f67565"], "package_ndc": ["0597-0152-90", "0597-0152-07", "0597-0152-70", "0597-0152-37", "0597-0152-30", "0597-0153-37", "0597-0153-30", "0597-0153-90", "0597-0153-07", "0597-0153-70"], "is_original_packager": [true], "nui": ["N0000187059", "N0000187058"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "unii": ["HDC1R2M35U"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0185-2024", "product_description": "Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877.  NDC: 0597-0153-37", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch D41919", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077042"], "brand_name": ["CITALOPRAM"], "generic_name": ["CITALOPRAM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-6231", "0378-6232", "0378-6233"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CITALOPRAM HYDROBROMIDE"], "rxcui": ["200371", "283672", "309314"], "spl_id": ["55e0b75b-3772-4f5b-a162-1f70719daf3d"], "spl_set_id": ["825c0c49-5fbf-6d8b-cb8c-94ebf0eda043"], "package_ndc": ["0378-6231-01", "0378-6231-05", "0378-6232-01", "0378-6232-05", "0378-6233-01", "0378-6233-05"], "is_original_packager": [true], "upc": ["0303786232017", "0303786231010", "0303786233014"], "unii": ["I1E9D14F36"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0173-2024", "product_description": "CITALOPRAM Tablets, USP, 20MG, 100 Tablets, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 0378-6232-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 3131748", "more_code_info": ""}, {"status": "Terminated", "city": "Verna", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA207016"], "brand_name": ["TELMISARTAN"], "generic_name": ["TELMISARTAN"], "manufacturer_name": ["Micro Labs Limited"], "product_ndc": ["42571-226", "42571-227", "42571-228"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TELMISARTAN"], "rxcui": ["205304", "205305", "282755"], "spl_id": ["f2aa8284-f86c-3425-e053-2995a90a6dc6"], "spl_set_id": ["d7c9bd41-9558-46e1-ab03-82cdf85db3fe"], "package_ndc": ["42571-226-30", "42571-226-90", "42571-226-05", "42571-226-10", "42571-226-32", "42571-226-11", "42571-226-41", "42571-227-30", "42571-227-90", "42571-227-05", "42571-227-10", "42571-227-32", "42571-227-11", "42571-227-41", "42571-228-30", "42571-228-90", "42571-228-05", "42571-228-10", "42571-228-32", "42571-228-11", "42571-228-41"], "is_original_packager": [true], "upc": ["0342571228309", "0342571226305", "0342571227302"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["U5SYW473RQ"]}, "product_type": "Drugs", "event_id": "93965", "recalling_firm": "Micro Labs Limited", "address_1": "Plot# S - 155", "address_2": "& N1 Phase Iii & Phase Iv; Verna Ind Estate Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico, TN, RI", "recall_number": "D-0388-2024", "product_description": "Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30.", "product_quantity": "118,080 bottles", "reason_for_recall": "Failed Stability Specifications: Out of specification for blend uniformity.", "recall_initiation_date": "20240209", "center_classification_date": "20240314", "termination_date": "20250624", "report_date": "20240320", "code_info": "Lot #s: SFBG024, SFBG025, Exp. 05/31/2024"}, {"status": "Ongoing", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018565"], "brand_name": ["INFUMORPH 200"], "generic_name": ["MORPHINE SULFATE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-6039", "0641-6040"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INTRATHECAL"], "substance_name": ["MORPHINE SULFATE"], "rxcui": ["892652", "1731522", "1731998", "1731999"], "spl_id": ["cd3674c8-d894-4dcf-8044-7a1198ed8ed9"], "spl_set_id": ["db9ac9e3-d761-4a99-9f34-4946ebe8f255"], "package_ndc": ["0641-6039-01", "0641-6040-01"], "is_original_packager": [true], "unii": ["X3P646A2J0"]}, "product_type": "Drugs", "event_id": "94208", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0392-2024", "product_description": "Infumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured by Hikma Berkeley Heights, NJ 07922, NDC 0641-6039-01", "product_quantity": "22,644 ampuls", "reason_for_recall": "The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.", "recall_initiation_date": "20240312", "center_classification_date": "20240321", "report_date": "20240327", "code_info": "Lot #:  052001, 052003, Exp. Date 11/2024; 023012, 023014, Exp. Date 08/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93829", "recalling_firm": "IntegraDose Compounding Services LLC", "address_1": "719 Kasota Ave Se", "address_2": "N/A", "postal_code": "55414-2842", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MN only", "recall_number": "D-0258-2024", "product_description": "Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1", "product_quantity": "281 syringes", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240112", "center_classification_date": "20240122", "report_date": "20240131", "code_info": "Lot #: 20230921VAS-2, Exp. Date 03/19/2024"}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076286"], "brand_name": ["TIZANIDINE"], "generic_name": ["TIZANIDINE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-179", "55111-180"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TIZANIDINE HYDROCHLORIDE"], "rxcui": ["313412", "313413"], "spl_id": ["386ec98d-4a47-b025-b050-7e4ebce382c6"], "spl_set_id": ["a42f3479-f2c2-8214-d547-c5cae9bfed1e"], "package_ndc": ["55111-179-30", "55111-179-15", "55111-179-03", "55111-179-10", "55111-180-30", "55111-180-15", "55111-180-03", "55111-180-10"], "is_original_packager": [true], "upc": ["0355111180104", "0355111179108"], "unii": ["B53E3NMY5C"]}, "product_type": "Drugs", "event_id": "93713", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0223-2024", "product_description": "Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15", "product_quantity": "38,952 bottles", "reason_for_recall": "Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.", "recall_initiation_date": "20240102", "center_classification_date": "20240111", "report_date": "20240117", "code_info": "Lot #: T2304007, Exp 7/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075478"], "brand_name": ["NORTREL 7/7/7"], "generic_name": ["NORETHINDRONE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["310463", "312033", "392662", "748797", "749852", "762007"], "spl_id": ["ddd9ebd7-bd21-4247-a158-95c5fc757aef"], "spl_set_id": ["992dcc56-90ab-4691-8114-16d47a8b9982"], "package_ndc": ["0555-9012-79", "0555-9012-58"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "93867", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-0322-2024", "product_description": "Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton contains 6 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9012-58", "product_quantity": "19,824 cartons", "reason_for_recall": "Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.", "recall_initiation_date": "20240125", "center_classification_date": "20240212", "report_date": "20240221", "code_info": "Lot #: 100040731, Exp 7/31/2024"}, {"status": "Terminated", "city": "Zug", "state": "N/A", "country": "Switzerland", "classification": "Class II", "openfda": {"application_number": ["ANDA212309"], "brand_name": ["FOSAPREPITANT"], "generic_name": ["FOSAPREPITANT"], "manufacturer_name": ["BE Pharmaceuticals Inc."], "product_ndc": ["71839-104"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["FOSAPREPITANT DIMEGLUMINE"], "rxcui": ["1731077"], "spl_id": ["1b1fe4ce-02d6-4ca1-8168-37b099caa434"], "spl_set_id": ["21b08b87-70e3-4233-9531-dd6d84eab5d0"], "package_ndc": ["71839-104-01"], "is_original_packager": [true], "upc": ["0371839104017"], "unii": ["D35FM8T64X"]}, "product_type": "Drugs", "event_id": "93747", "recalling_firm": "BE PHARMACEUTICALS AG", "address_1": "Bundesstrasse 3", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0262-2024", "product_description": "Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.", "product_quantity": "22,176 Vials", "reason_for_recall": "Lack of Sterility Assurance: Aseptic process simulation failure.", "recall_initiation_date": "20240110", "center_classification_date": "20240125", "termination_date": "20250610", "report_date": "20240131", "code_info": "lot #13D012AA, Exp: 08/31/2025"}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0255-2024", "product_description": "Secret, Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Lavender, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-383-10, UPC: 0 37000 72986 0", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077538"], "brand_name": ["FLUTICASONE PROPIONATE"], "generic_name": ["FLUTICASONE PROPIONATE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0829"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["FLUTICASONE PROPIONATE"], "rxcui": ["1797907"], "spl_id": ["de4b94c3-9864-33f5-8afe-ec494562de52"], "spl_set_id": ["3830675d-b45e-fc97-1f73-674b1fc38c80"], "package_ndc": ["60505-0829-1"], "is_original_packager": [true], "unii": ["O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "93974", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0326-2024", "product_description": "Fluticasone Propionate Nasal Spray USP 50mcg,  120 Metered Sprays - 16 g net fill, Rx Only,  Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9, Manufactured for: Apotex Corp Weston, FL 33326. NDC 60505-0829-1", "product_quantity": "292,752 bottles", "reason_for_recall": "CGMP Deviations: potential presence of Burkholderia cepacia complex", "recall_initiation_date": "20240209", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "Lot number # TX5274 Exp. 09/30/2026"}, {"status": "Completed", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204200"], "brand_name": ["ADRENALIN"], "generic_name": ["EPINEPHRINE", "EPINEPRINE"], "manufacturer_name": ["ENDO USA, Inc.", "Henry Schein, Inc."], "product_ndc": ["42023-159", "42023-168", "0404-9810"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["EPINEPHRINE"], "rxcui": ["310132", "1490057", "1660014", "1660016"], "spl_id": ["ed8fb63a-8526-4e61-adb4-4da9d3d4f2a0", "d61797df-009f-4a42-ba7d-64fff2d7a321"], "spl_set_id": ["3b7a4364-668d-4eb2-a20c-04adc35aabe4", "b293ad8e-7055-4a95-a130-9d7d74f19eab"], "package_ndc": ["42023-159-01", "42023-159-25", "42023-168-01", "0404-9810-01"], "is_original_packager": [true], "upc": ["0342023168016"], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"], "original_packager_product_ndc": ["42023-159"]}, "product_type": "Drugs", "event_id": "93839", "recalling_firm": "Henry Schein Inc. and Glove Club HSI Gloves Inc.", "address_1": "135 Duryea Rd", "address_2": "N/A", "postal_code": "11747-3834", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0342-2024", "product_description": "Adrenalin (epinephrine) Injection 1mg/mL, 1mL single dose vial, Rx only, Packaged By: Henry Schein, Inc., 80 Summit View Lane, Bastian, VA 24314, Original NDC 42023-159-25 Repack NDC 0404-9810-01", "product_quantity": "1,099 Single Dose Vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date. The expiration date listed on the Repack Pouch Label is incorrect.", "recall_initiation_date": "20240117", "center_classification_date": "20240221", "report_date": "20240228", "code_info": "Original Lot # 64103, exp. date 11/24 Repackaged Lot # 39747, exp. date 01/26"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040796"], "brand_name": ["FOLIC ACID"], "generic_name": ["FOLIC ACID"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-127"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FOLIC ACID"], "rxcui": ["310410"], "spl_id": ["92322e52-3179-4738-8c8a-14fef62311d4"], "spl_set_id": ["1ba8c407-9613-4319-ac40-0a429cb0f3f4"], "package_ndc": ["69315-127-01", "69315-127-10"], "is_original_packager": [true], "unii": ["935E97BOY8"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0183-2024", "product_description": "FOLIC ACID TABLETS, USP, 1MG, 100 Tablets per bottle, Rx Only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004.  NDC: 69315-127-10", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch H08221", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214554"], "brand_name": ["FOSFOMYCIN TROMETHAMINE"], "generic_name": ["FOSFOMYCIN TROMETHAMINE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-749"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FOSFOMYCIN TROMETHAMINE"], "rxcui": ["808917"], "spl_id": ["f6a079bc-179c-46e4-9077-96168cdd1cf9"], "spl_set_id": ["48e352bc-52ea-4778-905a-60ef38a5c18a"], "package_ndc": ["67877-749-57"], "is_original_packager": [true], "unii": ["7FXW6U30GY"]}, "product_type": "Drugs", "event_id": "93816", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0339-2024", "product_description": "Fosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of fosfomycin), single-dose sachet, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC. Parsippany, NJ 07054. NDC 67877-749-57", "product_quantity": "71,244 sachets", "reason_for_recall": "Failed Impurities/Degradation Specification: Out of specification for organic impurities", "recall_initiation_date": "20240116", "center_classification_date": "20240220", "report_date": "20240228", "code_info": "lOTS #: 22121458, 22121459, 22121460, 22121461, 22121462, 22121463, 22121464, Exp 4/2024; 22121176, 22121407, 22121465, Exp 3/2024; 22121761, 22121762, 22121763, 22121764, 22121766, 22121968, 22121969, Exp 5/2024."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209954"], "brand_name": ["ALBUTEROL SULFATE"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-963"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["2123072"], "spl_id": ["ca017981-2752-46e0-9a66-418535597d31"], "spl_set_id": ["973b8686-c6ce-4280-85c4-c1e7ceab3c09"], "package_ndc": ["68180-963-01"], "is_original_packager": [true], "upc": ["0368180963011"], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0163-2024", "product_description": "ALBUTEROL SULFATE IN 90MCG per actuation, 200 Metered Inhalations, Rx Only, 8.5 g Net Contents, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India.  NDC: 68180-963-01", "product_quantity": "11 cartons", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch K100715", "more_code_info": ""}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0382-2024", "product_description": "TRP Natural Eyes Pink Eye Relief, Sterile Eye Drops, Homeopathic, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-013-15.", "product_quantity": "139,656 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: P516, Exp: 03-24-2024, P517, Exp: 08-31-2024, P518, Exp:10-20-2024, P519, Exp: 03-09-2025, P520, Exp: 10-19-2025, P521, Exp: 11-09-2025, P522, Exp: 11-16-2025, P523, Exp: 01-18-2026, P524, Exp: 04-26-2026, P525, Exp: 05-10-2026, P526, Exp: 06-07-2026"}, {"status": "Ongoing", "city": "Portland", "state": "OR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93941", "recalling_firm": "Today The World", "address_1": "1954 NE Glisan St # 405", "address_2": "N/A", "postal_code": "97220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product distributed nationwide within the United States.", "recall_number": "D-0344-2024", "product_description": "SCHWINNNG Herbal Dietary Supplement, packaged in 10 capsules per box, Distributed by: Today the World LLC, Vancouver, WA 98683", "product_quantity": "11500 boxes", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the treatment of male sexual enhancement, making this drug an unapproved drug.", "recall_initiation_date": "20240206", "center_classification_date": "20240222", "report_date": "20240228", "code_info": "Lot #: 2108, Exp. Date 10/31/2024."}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0378-2024", "product_description": "TRP Natural Eyes Dryness Relief, Sterile Eye Drops, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-178-15.", "product_quantity": "47,832 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: D101, Exp: 07-01-2024, D102, Exp: 12-01-2024, D103, Ep: 04-13-2025"}, {"status": "Terminated", "city": "Rosenberg", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93986", "recalling_firm": "Seatex LLC", "address_1": "445 Highway 36 N", "address_2": "", "postal_code": "77471-8756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0358-2024", "product_description": "7 Eleven FOR GAS ISLAND USE ONLY, Hand Sanitizer, Ethanol 70% v/v Antiseptic, Mountain Spring Scent, 330 Gal. cases, Distributed by: Magnus, 16005 Gateway Drive, Suite 300, Frisco, TX 75033", "product_quantity": "3 cases", "reason_for_recall": "CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.", "recall_initiation_date": "20240219", "center_classification_date": "20240229", "termination_date": "20250815", "report_date": "20240306", "code_info": "Lot #: 251176, Exp. 06/23/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211815"], "brand_name": ["FLUOCINOLONE ACETONIDE"], "generic_name": ["FLUOCINOLONE ACETONIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-185"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["AURICULAR (OTIC)"], "substance_name": ["FLUOCINOLONE ACETONIDE"], "rxcui": ["1191299"], "spl_id": ["cc1f615e-6cb2-4721-84c6-e5f170b64d90"], "spl_set_id": ["a00224b0-3db5-4d40-b370-5ec5476e1e10"], "package_ndc": ["68462-185-56"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["0CD5FD6S2M"]}, "product_type": "Drugs", "event_id": "93719", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0259-2024", "product_description": "Fluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Village: Kishanpura, Baddi Nalagarh Road, District: Solan, Himachal Pradesh - 173205, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-185-56", "product_quantity": "38,496 bottles", "reason_for_recall": "Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol", "recall_initiation_date": "20240104", "center_classification_date": "20240122", "termination_date": "20240816", "report_date": "20240131", "code_info": "Lot #: 05220346, 05220369 Exp 1/31/ 2024; 05220582, Exp 2/29/2024; 05220861 Exp 3/31/2024"}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0384-2024", "product_description": "hyalogic For Dry Eyes, HylaTears\", Lubricant Eye Drops, 0.67 FL OZ (20mL) bottle, Manufactured for hyalogic, 610 NW Platte Valley Dr., Riverside, MO 64150", "product_quantity": "46,621 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "All lots within Expiry"}, {"status": "Ongoing", "city": "Thane", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93885", "recalling_firm": "Brassica Pharma Pvt Ltd", "address_1": "Plot No. T-68, T 68 (Pt), T-63, Midc", "address_2": "Tarapur, Boisar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0352-2024", "product_description": "Equate Stye Lubricant Eye Ointment (Mineral Oil 31.9%, White Petrolatum 57.7%), Packaged in 3.5 g tubes, Distributed by Walmart Inc., Bentonville, AR 72716, NDC 79903-028-35, UPC 681131395304", "product_quantity": "355,633 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240130", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #: A2D08, Exp. Date Mar-24; A2F02, Exp. Date May-24;  A2I03, Exp. Date Aug-24; A2L03, A2L04, Exp. Date Nov-24; A3C03, A3C05, Exp. Date Feb-25 A3H01, A3H03, Exp. Date Jul-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Portland", "state": "OR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93941", "recalling_firm": "Today The World", "address_1": "1954 NE Glisan St # 405", "address_2": "N/A", "postal_code": "97220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product distributed nationwide within the United States.", "recall_number": "D-0343-2024", "product_description": "Sustain Herbal Dietary Supplement, packaged in 10 capsules per box, Distributed by VSD Productions, Inc. Las Vegas, Nevada", "product_quantity": "7000 boxes", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this drug an unapproved drug.", "recall_initiation_date": "20240206", "center_classification_date": "20240222", "report_date": "20240228", "code_info": "Lot #: BTH:230551, Exp. Date 12.05.2026; BTH:230571, Exp. Date 14.05.2026"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020983"], "brand_name": ["ALBUTEROL SULFATE"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["Prasco Laboratories"], "product_ndc": ["66993-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["2123076"], "spl_id": ["900ad6e1-b46b-47e4-90e5-80cd44a42e40"], "spl_set_id": ["b25d9d6b-eb4c-452e-89ef-10e611deebd6"], "package_ndc": ["66993-019-68"], "is_original_packager": [true], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0162-2024", "product_description": "ALBUTEROL SULFATE HFA Inhalation Aerosol, 90MCG per actuation, 200 Metered Inhalations, Net Wt. 18 g, Rx Only, Manufactured for: Prasco Laboratories, Mason, OH 45040 USA.  NDC: 66993-019-68", "product_quantity": "2 cartons", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch MY7E", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211020"], "brand_name": ["BUPROPION HYDROCHLORIDE"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-862", "16571-863"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993541", "993557"], "spl_id": ["a047dcfb-9b8c-446e-815e-2ee800cc7b79"], "spl_set_id": ["e4f4d3fa-ddf6-4125-8486-8157efc095c1"], "package_ndc": ["16571-862-03", "16571-862-09", "16571-862-50", "16571-862-10", "16571-862-12", "16571-863-03", "16571-863-09", "16571-863-50", "16571-863-10"], "is_original_packager": [true], "upc": ["0316571862030", "0316571863037"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "93706", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0222-2024", "product_description": "buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03", "product_quantity": "47,976 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules", "recall_initiation_date": "20231229", "center_classification_date": "20240111", "report_date": "20240117", "code_info": "Lot #: BPA123098A, Exp. Date 06/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0245-2024", "product_description": "Secret, Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Light Essentials, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC:  69423-382-10, UPC 0 37000 72992 1", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0309-2024", "product_description": "Lubricant Eye Drops (Propylene glycol 0.6%), packaged in 0.33 FL OZ (10 mL) each bottle (Twin Pack), Distributed by: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-4811-3 Retail Labeler: Rite Aid", "product_quantity": "7,296 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93500", "recalling_firm": "AnazaoHealth Corporation", "address_1": "7465 W Sunset Rd Ste 1200", "address_2": "", "postal_code": "89113-1944", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0203-2024", "product_description": "B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3", "product_quantity": "5,707 vials", "reason_for_recall": "Presence of Particulate Matter.", "recall_initiation_date": "20231122", "center_classification_date": "20231226", "termination_date": "20250929", "report_date": "20240103", "code_info": "Lots: 505075, Exp: 02/05/24; 505596, Exp: 02/06/24; 506155, Exp: 02/07/24; 508103, Exp: 02/13/24; 510837, Exp: 02/19/24; 512411, Exp: 02/20/24; 514856, Exp: 02/25/24; 515642, Exp: 02/28/24; 518309, Exp: 03/05/24; 524262, 524266, Exp: 03/12/24; 524909, Exp: 03/13/24; 526526, Exp: 03/16/24; 529204, Exp: 03/18/24; 530858, Exp: 03/20/24; 535766, Exp: 03/30/24", "more_code_info": ""}]